We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+2.53%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$5.41B
AUM Growth
+$138M
Cap. Flow
+$23.7M
Cap. Flow %
0.44%
Top 10 Hldgs %
64.34%
Holding
812
New
73
Increased
397
Reduced
244
Closed
59

Sector Composition

Rank Sector Weight
1 Technology 6.31%
2 Financials 2.57%
3 Healthcare 2.28%
4 Communication Services 1.78%
5 Consumer Discretionary 1.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUZ icon
801
Suzano
SUZ
$10.5B
-12,055
Closed -$154K
TEAM icon
802
Atlassian
TEAM
$25.6B
-1,275
Closed -$249K
TROW icon
803
T. Rowe Price
TROW
$23.9B
-1,658
Closed -$202K
UNIT
804
Uniti Group
UNIT
$2.36B
-33,502
Closed -$198K
USMV icon
805
iShares MSCI USA Min Vol Factor ETF
USMV
$23.5B
-3,662
Closed -$306K
VDC icon
806
Vanguard Consumer Staples ETF
VDC
$7.97B
-8,431
Closed -$1.72M
VICI icon
807
VICI Properties
VICI
$29B
-11,466
Closed -$342K
VIPS icon
808
Vipshop
VIPS
$7.37B
-11,449
Closed -$189K
XBI icon
809
State Street SPDR S&P Biotech ETF
XBI
$9.95B
-27,066
Closed -$2.57M
XLI icon
810
State Street Industrial Select Sector SPDR ETF
XLI
$32.8B
-1,647
Closed -$207K
SWAV
811
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
-825
Closed -$269K
PXD
812
DELISTED
Pioneer Natural Resource Co.
PXD
-1,198
Closed -$314K

Similar funds

Ballentine Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ballentine Partners held 812 positions worth $5.41B, up 2.6% from $5.27B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Ballentine Partners's Q2 2024 filing shows 73 new, 397 increased, 244 reduced and 59 closed positions. Its largest new stake was Forrester Research: 250,057 shares worth $4.27M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $11.9M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, up from 5.6% a quarter earlier, followed by Financials and Healthcare.

  • Ballentine Partners's largest Q2 2024 buy was Forrester Research: 250,057 shares worth $4.27M.
  • Ballentine Partners added most to iShares Core MSCI EAFE ETF in Q2 2024, an estimated $11.9M increase.
  • Ballentine Partners's biggest Q2 2024 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $11.9M.
  • Ballentine Partners fully exited State Street SPDR S&P Biotech ETF in Q2 2024, selling an estimated $2.57M.
  • Ballentine Partners's ten largest holdings make up 64% of its $5.41B portfolio in Q2 2024.
  • Ballentine Partners opened 73 new positions and closed 59 in Q2 2024.
  • Ballentine Partners's portfolio value rose 2.6% quarter-over-quarter to $5.41B.

Based on Ballentine Partners's 13F filing for Q2 2024, filed 6 Aug 2024.